ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 23rd, 2021 • Aerpio Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 23rd, 2021 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into as of August 17, 2021 (the “Effective Date”), by and between Aerpio Pharmaceuticals, Inc., a Delaware corporation on behalf of itself and its wholly-owned subsidiaries (“Seller”), and EyePoint Pharmaceuticals, Inc., a Delaware corporation (“Purchaser”).